Innovative vaccines and biotherapeutics made by Bharat Biotech are renowned among medical professionals around. Our products assist individuals in more than 125 nations to live fully. We have 215 patents. The USFDA, KFDA, and WHO have all certified our manufacturing facilities. We have distributed more than 4 billion doses of vaccination over the world. By creating novel vaccines and medicines, our top objective is to address the health issues facing the poor globe. Since our early years, we have made investments in cutting-edge research in fields that require quick medical fixes. This concentration resulted in a string of efficient vaccinations leaving our laboratories and having a long-lasting effect on the health of millions. We have distributed more than 4 billion doses of vaccination over the world. One of the top products in the wound healing market is REGEN-D®, our epidermal growth factor for diabetic foot ulcers and burns. Our top objective is to find solutions for the health issues facing the developing globe. To prevent viral infections like Chikungunya and Zika, we were among the first to create vaccinations. Our DNA is fundamentally open and transparent. We stand out for our unwavering commitment to integrity. We are renowned for the rigor and scope of our clinical trials. To ensure that we accurately collect, preserve, and report data, we also implement the most thorough data integrity protocols. Given the significance of the work we undertake, we only hire the most intelligent individuals. With a dual focus on innovation and quality, over 700 employees—research scientists and manufacturing experts—collaborate to develop vaccines and treatments. We are well-positioned for significant expansion in the upcoming years because of our top-notch research and manufacturing skills as well as our focus on diseases in the developing globe.